BUY Ajanta Pharma Limited — Manas Jaiswal
Ajanta Pharma share price target & all analyst calls
byManas JaiswalHorizon: NA (inferred Intraday)23 Oct 2026, 9:33 am ISTvia CNBC Awaaz.
Entry₹3,331Inferred
Stop loss₹3,275-1.68% risk
Exit₹3,275Stop-loss hit — time not yet verified
Stop-loss hit-1.68%
Follow Manas Jaiswal for new calls(12% target hit, 146 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 7 active Intraday picks this session
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
1 supporting1 neutral0 opposing
Supports the BUY call (1)
RSI at 24 — oversold territory
Technicals · rsi·23 Oct · today
Neutral / worth noting (1)
Weighs against the BUY call (0)
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Ajanta Pharma
- BUY — Aastha Jain, Hem Securities30 Sept 2026 · Next day · target ₹3,800 · SL hit
- BUY — Sahi Research24 Sept 2026 · ~2 weeks · target ₹3,780 · SL hit
- BUY — Siddharth Rai Mangala18 Sept 2026 · ~2 weeks · target ₹3,770 · SL hit
- BUY — Kshitija Salvi, Globe Capital Market8 Sept 2026 · ~2 weeks · target ₹3,825 · SL hit
- BUY — Kush Bohra17 Aug 2026 · ~2 weeks · target ₹3,860 · SL hit
More from Manas Jaiswal
- BUY Torrent Pharmaceuticals23 Oct 2026 · Same day · target ₹4,725 · SL hit
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹50 · SL hit
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · Active
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY Coforge22 Oct 2026 · Same day · target ₹2,010 · SL hit